Prolonged Treatment with Brentuximab Vedotin (SGN-35) in Patients with Relapsed or Refractory Hodgkin Lymphoma (HL) or Systemic Anaplastic Large Cell Lymphoma (sALCL),

Autor:	Forero-Torres, Andres, Berryman, R. Brian, Advani, Ranjana H., Bartlett, Nancy L., Chen, Robert W., Fanale, Michelle A., Gopal, Ajay K., O'Connor, Owen A., Olshefski, Randal *, Smith, Scott E. *, Grove, Laurie E. *, Matous, Jeffrey
Zdroj:	In Blood 18 November 2011 118(21):3711-3711
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu